沙库巴曲缬沙坦联合美托洛尔治疗慢性心力衰竭患者的效果OA
Effect of Sacubitril and Valsartan Combined with Metoprolol in the Treatment of Patients with Chronic Heart Failure
目的:研究沙库巴曲缬沙坦联合美托洛尔治疗慢性心力衰竭(CHF)患者的效果.方法:选取 2022 年 1 月—2023 年 9 月重庆市万盛经济技术开发区中医院收治的 94 例CHF患者.根据随机数表法将其分为研究组和对照组,各 47 例.对照组给予美托洛尔,研究组给予美托洛尔联合沙库巴曲缬沙坦.比较两组治疗前后血清学指标、心功能指标、炎症因子、血管内皮功能指标及不良反应.结果:治疗后,研究组氨基末端脑钠肽前体(NT-proBNP)、细胞间黏附分子…查看全部>>
Objective:To study the effect of Sacubitril and Valsartan combined with Metoprolol in the treatment of patients with chronic heart failure(CHF).Method:A total of 94 CHF patients admitted to the Chongqing Wansheng Economic and Technological Development Zone Traditional Chinese Medicine Hospital from January 2022 to September 2023 were selected.According to random number table method,the patients were divided into study group and control group,47 cases in each…查看全部>>
刘洪波
重庆市万盛经济技术开发区中医院 重庆 400800
慢性心力衰竭沙库巴曲缬沙坦美托洛尔心功能
Chronic heart failureSacubitril and valsartanMetoprololCardiac function
《中外医学研究》 2024 (18)
59-63,5
评论